{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:03:19Z","timestamp":1779897799090,"version":"3.53.1"},"reference-count":44,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274117"],"award-info":[{"award-number":["82274117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["ZYYZDXK-2023257"],"award-info":[{"award-number":["ZYYZDXK-2023257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"High-level Key Discipline Construction Program of National Administration of Traditional Chinese Medicine","award":["82274117"],"award-info":[{"award-number":["82274117"]}]},{"name":"High-level Key Discipline Construction Program of National Administration of Traditional Chinese Medicine","award":["ZYYZDXK-2023257"],"award-info":[{"award-number":["ZYYZDXK-2023257"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>The definition of pharmacovigilance was first proposed in the 1970s to safeguard public health and the safety of drug use, and to improve the quality of life of patients. China\u2019s traditional medicine has also always contained the idea of vigilance for the safe use of medicines in the process of development. In this article, we will discuss the origin and development of the idea of pharmacovigilance in China, the establishment of a realistic system, and the current status of pharmacovigilance construction, and look forward to the development of pharmacovigilance in the future.<\/jats:p>","DOI":"10.3390\/pharmacy13040090","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:55:43Z","timestamp":1751442943000},"page":"90","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Historical Process, Status and Future Development of Pharmacovigilance Systems in Chinese Medicine"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0201-3938","authenticated-orcid":false,"given":"Xue","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2002-3202","authenticated-orcid":false,"given":"Yinfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100029, China"},{"name":"Research Center for Pharmacovigilance and Rational Use of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-068X","authenticated-orcid":false,"given":"Zhijian","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100029, China"},{"name":"Research Center for Pharmacovigilance and Rational Use of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"ref_1","first-page":"1755","article-title":"Analysis of the knowledge system of pharmacovigilance system","volume":"39","author":"Wang","year":"2022","journal-title":"Chin. Mod. Appl. Pharmacol."},{"key":"ref_2","unstructured":"Begaud, B. (1993). Methodological Approaches in Pharmacoepidemiology: Application to Spontaneous Reporting, Elsevier Science Publishers."},{"key":"ref_3","first-page":"718","article-title":"Pharmacovigilance and clinical pharmacy services","volume":"23","author":"Zeng","year":"2014","journal-title":"J. Pharmacoepidemiol."},{"key":"ref_4","unstructured":"Collaborating Centre for International Drug Monitoring (2002). The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products, World Health Organization."},{"key":"ref_5","unstructured":"(1983, January 6\u201321). Drug Administration Law of the People\u2019s Republic of China. Proceedings of the Sixth National People\u2019s Congress, Beijing, China."},{"key":"ref_6","unstructured":"State Drug Administration (2019, August 27). Drug Administration Law of the People\u2019s Republic of China, Available online: https:\/\/www.nmpa.gov.cn\/xxgk\/fgwj\/flxzhfg\/20190827083801685.html."},{"key":"ref_7","first-page":"2017","article-title":"Pharmacovigilance ideas of traditional Chinese medicine based on the practice of \u201cknow poison\u2014Use poison\u2014Prevent poison\u2014Detoxify\u201d","volume":"42","author":"Zhang","year":"2017","journal-title":"Chin. J. Tradit. Chin. Med."},{"key":"ref_8","unstructured":"Liu, A., and Gao, X. (1989). Huainanzi, Shanghai Ancient Books Publishing House."},{"key":"ref_9","unstructured":"Zheng, X., and Cui, G. (1997). The Rites of the Zhou, Liaoning Education Press."},{"key":"ref_10","first-page":"17","article-title":"An analysis of the theory of medicinal properties in Huangdi Neijing","volume":"23","author":"Tang","year":"2011","journal-title":"J. Jiangxi Coll. Tradit. Chin. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5582\/bst.2019.01244","article-title":"The toxicity and safety of traditional Chinese medicines: Please treat with rationality","volume":"13","author":"Cai","year":"2019","journal-title":"Biosci. Trends."},{"key":"ref_12","first-page":"257","article-title":"The historical development of traditional Chinese pharmacovigilance thought","volume":"5","author":"Wu","year":"2006","journal-title":"Chin. Pharmacovigil."},{"key":"ref_13","first-page":"987","article-title":"An analysis of the idea of drug caution in the writings of the Five Dynasties of the Sui and Tang Dynasties","volume":"19","author":"Jiang","year":"2022","journal-title":"Chin. Pharmacovigil."},{"key":"ref_14","first-page":"1166","article-title":"Advances in research on contraindications to drug use during pregnancy","volume":"27","author":"Wu","year":"2012","journal-title":"J. Chin. Med."},{"key":"ref_15","first-page":"55","article-title":"Study on connotation and procedure of ZHANG Bing\u2019s clinical medication notification","volume":"42","author":"Li","year":"2023","journal-title":"Beijing J. Tradit. Chin. Med. China"},{"key":"ref_16","first-page":"347","article-title":"A study on the idea of drug literacy and vigilance in the Materia Medica","volume":"16","author":"Shi","year":"2019","journal-title":"Chin. Pharmacovigil."},{"key":"ref_17","unstructured":"Qing-Ling, H. (1982). This Herb is Harmful, Chinese Medicine Ancient Books Publishing House."},{"key":"ref_18","first-page":"4751","article-title":"Exploration of the idea of caution in Qing Dynasty herbal works","volume":"44","author":"Qu","year":"2019","journal-title":"Chin. J. Tradit. Chin. Med."},{"key":"ref_19","first-page":"51","article-title":"Interpretation of pharmacovigilance in the regulatory science perspective","volume":"38","author":"Shu","year":"2022","journal-title":"J. Guangdong Pharm. Univ."},{"key":"ref_20","unstructured":"National Medical Products Administration (2018). Announcement on Direct Reporting of Adverse Reactions by Drug Marketing Authorization Holders (No. 66 of 2018)."},{"key":"ref_21","first-page":"754","article-title":"Reflections on the construction of drug traceability system in China","volume":"34","author":"Zhang","year":"2020","journal-title":"China Pharm. Aff."},{"key":"ref_22","unstructured":"Lok, N. (2022). The State Drug Administration Issued the Guidelines for Pharmacovigilance Inspection, China Pharmaceutical News."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","article-title":"Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet"},{"key":"ref_24","unstructured":"(2004). State Drug Administration Adverse Drug Reaction Notice. World Clin. Drug, 3, 179."},{"key":"ref_25","unstructured":"(2008). State Food and Drug Administration informs about the investigation and handling of adverse events of Acanthopanax. World Clin. Drug, 29, 691."},{"key":"ref_26","unstructured":"(2011). Adverse drug reaction reporting and monitoring management approach. Bull. Minist. Health People\u2019s Repub. China, 6, 1\u201310."},{"key":"ref_27","unstructured":"Shen, C. (2021). Practicing \u201cNine Musts\u201d to Create a New Situation of Monitoring and Evaluation and Pharmacovigilance, China Pharmaceutical News."},{"key":"ref_28","first-page":"407","article-title":"Safety evaluation and pharmacovigilance of Chinese medicines","volume":"66","author":"Xiao","year":"2021","journal-title":"Sci. Bull."},{"key":"ref_29","first-page":"87","article-title":"Current situation and suggestions for the development of Chinese herbal medicine cultivation","volume":"5","author":"Lang","year":"2021","journal-title":"Agric. Technol. Equip."},{"key":"ref_30","unstructured":"World Health Organization (2004). Pharmacovigilance: Ensuring the Safe Use of Medicines, WHO."},{"key":"ref_31","first-page":"23","article-title":"Reflections on the establishment of pharmacovigilance system in China","volume":"8","author":"Tian","year":"2020","journal-title":"China Food Drug Adm."},{"key":"ref_32","first-page":"2017","article-title":"Future-oriented reflections on the implementation of pharmacovigilance system in China","volume":"30","author":"Zhang","year":"2021","journal-title":"Chin. J. New Drugs"},{"key":"ref_33","first-page":"749","article-title":"Preliminary thoughts on the establishment of pharmacovigilance system in China","volume":"17","author":"Yuan","year":"2020","journal-title":"China Pharmacovigil."},{"key":"ref_34","first-page":"56","article-title":"The main manifestations of unbalanced and insufficient economic and social development in China","volume":"2","author":"Cao","year":"2018","journal-title":"China Ind. Econ."},{"key":"ref_35","first-page":"181","article-title":"Research on the problems and countermeasures in Internet drug sales","volume":"2","author":"Tan","year":"2022","journal-title":"Enterp. Technol. Dev."},{"key":"ref_36","first-page":"108","article-title":"Regulatory difficulties and governance path of telemedicine platforms (in English)","volume":"2","author":"Huo","year":"2022","journal-title":"Sci. Technol. Law"},{"key":"ref_37","unstructured":"Sun, W., Wang, Y., He, L., Yi, F., and Professional Committee of Clinical Chinese Medicine, Chinese Pharmaceutical Society (2018, January 8). Current status and development of pharmacovigilance research in China. Proceedings of the Second Congress of Clinical Chinese Medicine, Beijing, China."},{"key":"ref_38","first-page":"233","article-title":"An overview of pharmacovigilance in Chinese medicine","volume":"25","author":"Gao","year":"2019","journal-title":"Chin. J. Basic Chin. Med."},{"key":"ref_39","first-page":"333","article-title":"Research and insights on the whole life cycle management of drug labeling in the United States","volume":"15","author":"Yu","year":"2018","journal-title":"China Pharmacovigil."},{"key":"ref_40","first-page":"637","article-title":"Research and reflection on the whole life cycle pharmacovigilance system of drugs","volume":"24","author":"Wang","year":"2022","journal-title":"China Pharm. J."},{"key":"ref_41","first-page":"406","article-title":"A comparative study of pharmacovigilance signal management systems in the European Union, the United States and Japan","volume":"32","author":"Shi","year":"2021","journal-title":"Chin. Pharm."},{"key":"ref_42","first-page":"354","article-title":"U.S. FDA sentinel actions and its inspiration for food and drug regulatory data management in China","volume":"31","author":"Zong","year":"2017","journal-title":"China Pharm. Aff."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jbi.2015.02.004","article-title":"Utilizing social media data for pharmacovigilance: A review","volume":"54","author":"Sarker","year":"2015","journal-title":"J. Biomed. Inform."},{"key":"ref_44","first-page":"5450","article-title":"Implications of international pharmacovigilance system for the establishment of pharmacovigilance system for traditional Chinese medicine","volume":"46","author":"Cui","year":"2021","journal-title":"Chin. J. Tradit. Chin. Med."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/13\/4\/90\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:59:02Z","timestamp":1760032742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/13\/4\/90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["pharmacy13040090"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy13040090","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}